ANG Lifesciences India share news, announcements and annual reports
BSE: 540694Pharmaceuticals & BiotechnologySmall Cap
ANG Lifesciences India Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2017
Last close ₹32.87up ₹0.78 (2.43%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹32.09.
2 Nov: open ₹32.09, high ₹34.50, low ₹31.00
52-week range of traded prices to 2 Nov 2026
₹17.63Low, 30 Mar 2026₹49.69High, 25 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43 Cr3,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −22.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −6.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.47
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,769
ANG Lifesciences India board meetings
102 filed, newest first. Page 1 of 3.
Sep 2026
Aug 2026
7 Aug · Board meeting
Meeting on 14 Aug 2026: quarterly results
May 2026
22 May · Board meeting
Meeting on 30 May 2026: audited results
Feb 2026
5 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Nov 2025
6 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Sep 2025
Aug 2025
6 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results
May 2025
30 May · Board meeting
22 May · Board meeting
Meeting on 30 May 2025: audited results
Feb 2025
6 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Nov 2024
7 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Aug 2024
7 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results
May 2024
24 May · Board meeting
Meeting on 30 May 2024: audited results
Feb 2024
7 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results
Nov 2023
14 Nov · Board meeting
6 Nov · Board meeting
Meeting on 14 Nov 2023: quarterly results
Sep 2023
5 Sep · Board meeting
Aug 2023
29 Aug · Board meeting
Meeting on 5 Sep 2023: annual general meeting7 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results
May 2023
23 May · Board meeting
Meeting on 30 May 2023: audited results
Apr 2023
5 Apr · Board meeting
Mar 2023
Feb 2023
27 Feb · Board meeting
Meeting on 6 Mar 2023: increase in authorised capital and preferential issue of shares14 Feb · Board meeting
6 Feb · Board meeting
Meeting on 14 Feb 2023: quarterly results
Nov 2022
7 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
17 Oct · Board meeting